Infographic 24 April 2015

Counterfeit medicines in legitimate supply chains SDCP &PSI Study


Analysis of reports over a five year period – from 2005 to 2010 – indicates that counterfeit medicines increased by 122% while diversion and theft
increased by 66%.

Improvements in surveillance, including detection of security breaches, data
collection, analysis, and dissemination are urgently needed to address the public
health need to combat the global counterfeit medicines trade.


Infographic pdf | 312KB
Counterfeit medicines in legitimate supply chains SDCP & PSI study - French pdf | 1.09MB


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster